Clinical utility of high-throughput glycome analysis in patients with pancreatic cancerKazuhiro Nouso, Kazuhide Yamamoto, Sayo Kobayashi et al.|Journal of Gastroenterology|2013Cited by 54
Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative ColitisKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|PLoS ONE|2013Cited by 51
Use of non‐invasive serum glycan markers to distinguish non‐alcoholic steatohepatitis from simple steatosisYasushi Yamasaki, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Journal of Gastroenterology and Hepatology|2014Cited by 28
Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenibKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Hepatology|2013Cited by 23
Alteration of <i><scp>N</scp></i>‐glycan profiles in patients with chronic hepatitis and hepatocellular carcinomaKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Hepatology Research|2014Cited by 19